agilon health, inc. Investment Income, Net
agilon health, inc. (AGL) reported Investment Income, Net of $2.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-08-05
- agilon health, inc. investment income, net for the quarter ending 2026-06-30 was $2.50M, a 30.56% decline year-over-year.
- agilon health, inc. investment income, net for the quarter ending 2026-03-31 was $2.80M, a 34.88% decline year-over-year.
- agilon health, inc. investment income, net for the quarter ending 2025-12-31 was $3.00M, a 30.23% decline year-over-year.
- agilon health, inc. investment income, net for the quarter ending 2025-09-30 was $3.80M, a 17.39% decline year-over-year.
- agilon health, inc. investment income, net for fiscal 2025 was $14.70M, a 23.44% decline from fiscal 2024.
- agilon health, inc. investment income, net for fiscal 2024 was $19.20M, a 31.18% decline from fiscal 2023.
- agilon health, inc. investment income, net for fiscal 2023 was $27.90M, a 92.41% increase from fiscal 2022.
- agilon health, inc. investment income, net for fiscal 2022 was $14.50M.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.50M 10-Q · filed 2026-08-05 | $5.40M 10-Q · filed 2026-08-05 | $8.30M derived: sum of 3 quarters · filed 2026-08-05 | $12.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $2.80M 10-Q · filed 2026-05-06 | $5.80M derived: sum of 2 quarters · filed 2026-05-06 | $9.60M derived: sum of 3 quarters · filed 2026-05-06 | $13.20M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $6.80M derived: sum of 2 quarters · filed 2026-02-25 | $10.40M derived: sum of 3 quarters · filed 2026-08-05 | $14.70M 10-K · filed 2026-02-25 |
| 2025-09-30 | $3.80M 10-Q · filed 2025-11-04 | $7.40M derived: sum of 2 quarters · filed 2026-08-05 | $11.70M 10-Q · filed 2025-11-04 | $16.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $3.60M 10-Q · filed 2026-08-05 | $7.90M 10-Q · filed 2026-08-05 | $12.20M derived: sum of 3 quarters · filed 2026-08-05 | $16.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $4.30M 10-Q · filed 2026-05-06 | $8.60M derived: sum of 2 quarters · filed 2026-05-06 | $13.20M derived: sum of 3 quarters · filed 2026-05-06 | $18.00M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $8.90M derived: sum of 2 quarters · filed 2026-02-25 | $13.70M derived: sum of 3 quarters · filed 2026-02-25 | $19.20M 10-K · filed 2026-02-25 |
| 2024-09-30 | $4.60M 10-Q · filed 2025-11-04 | $9.40M derived: sum of 2 quarters · filed 2025-11-04 | $14.90M 10-Q · filed 2025-11-04 | $21.40M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $4.80M 10-Q · filed 2025-08-04 | $10.20M 10-Q · filed 2025-08-04 | $16.80M derived: sum of 3 quarters · filed 2026-02-25 | $22.90M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $5.40M 10-Q · filed 2025-05-06 | $12.00M derived: sum of 2 quarters · filed 2026-02-25 | $18.10M derived: sum of 3 quarters · filed 2026-02-25 | $25.30M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $6.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $12.70M derived: sum of 2 quarters · filed 2026-02-25 | $19.90M derived: sum of 3 quarters · filed 2026-02-25 | $27.90M 10-K · filed 2026-02-25 |
| 2023-09-30 | $6.10M 10-Q · filed 2024-11-07 | $13.30M derived: sum of 2 quarters · filed 2024-11-07 | $21.30M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $7.20M 10-Q · filed 2024-08-06 | $15.50M 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $8.30M 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | $14.50M 10-K · filed 2025-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |